My watch list


Prof. Dr. Michael Bauer

Universitätsklinikum Jena, Klinik für Anästhesiologie und Intensivmedizin

Medienzentrum UKJ

Prof. Dr. med. Michael Bauer

Michael Bauer, born in 1963, is Professor and Chair of Anesthesiology and Intensive Care and chief executive director of the Center for Sepsis Control Care (CSCC) at University Hospital Jena, Germany. He received his M.D. from Saarland University and postgraduate training in molecular biology at Johns Hopkins University in Baltimore, USA (1993–1995). In 1997 he qualified as a professor in anesthesiology and intensive care medicine at Saarland University. After board certification in anesthesiology and intensive care, he was a visiting professor at the University of North Carolina in Charlotte (1998–1999). Dr. Bauer works on molecular mechanisms of sepsis and shock-related organ dysfunction with a focus on personalized, theranostic, and biophotonic strategies to visualize liver function.


Professor Bauer serves as member of the board of directors of the cluster of excellence “Balance of the Microverse” (EXC 2051; Project-ID 390713860) in the Jena Center for Soft Matter (JCSM), the research campus InfectoGnostics and the Leibniz Center for Photonics in Infection Research. He is vice-speaker of CRC (SFB) 1278 “Polymer-based nanoparticle libraries for targeted anti-inflammatory strategies” (PolyTarget) and chairman for Thuringia of the German Society for Anaesthesiology and Critical Care (DGAI).


Michael Bauer received a scholarship from the German National Academic Foundation and a Feodor Lynen scholarship from the Alexander von Humboldt Foundation. In 1996 he received the research award from the German Society for Anesthesiology and Intensive Care Medicine (research grant from the Fresenius Foundation) and the Manfred Specker Medal from the DGAI for mentoring. In 2015 he received the innovation award of the state of Thuringia & special award for young companies (SmartDyeLivery, GmbH) and in 2019 the Thuringian Research Award for Applied Research (RAMANBIOASSAYTM).


The main interest of Professor Bauer's work is nanomedicine with a focus on selective targeting of parenchymal and non-parenchymal cells of the liver, as well as target identification of RNAs, proteins and metabolites of the human systemic inflammatory response to pathogens and microbiome-host interactions in intensive care patients.


  • Omic profiling (transcriptomics, proteomics, metabolomics, next generation sequencing)
  • Biophotonics (in vivo microscopy and multimodal imaging)
  • Clinical trials

Facts, background information, dossiers

  • anesthesiology
  • intensive care medicine
  • sepsis
  • molecular medicine
  • nanomedicine
  • selective targeting
  • target identification
  • transcriptomics
  • proteomics
  • metabolomics
  • next generation sequencing
  • clinical trials
  • biophotonics

Other articles by this author

All articles

Effective drug navigation in sepsis

Many drug candidates never reach clinical use due to their side effects. For example, inhibitors of phosphoinositide 3-kinase-γ, a signaling protein that plays an important role in (…)

More about UKJ

  • News

    High-Performance Microscopy for Membrane Receptors

    In a new Collaborative Research Centre scientists from Würzburg and Jena are examining the function of membrane receptors with the most modern light microscopy. The objective is to gain new findings about how these receptors work and to develop the high-performance light microscopy further. ... more

  • q&more articles

    Effective drug navigation in sepsis

    Many drug candidates never reach clinical use due to their side effects. For example, inhibitors of phosphoinositide 3-kinase-γ, a signaling protein that plays an important role in infections, cannot be used because of their side effects on the immune response. more

  • Authors

    Prof. Dr. Adrian T. Press

    Adrian Press, born in 1989, studied molecular medicine for his bachelor’s and master’s degrees at Furtwangen and the Friedrich Schiller University in Jena, Germany. He then obtained his doctoral degree at the medical faculty in Jena researching novel theranostic nanoparticles. During his po ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:


Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE